Search Results

There are 19892 results for: content related to: Brain activity and emotional processing in smokers treated with varenicline

  1. You have free access to this content
    Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe and Tim Lancaster

    Published Online : 9 MAY 2016, DOI: 10.1002/14651858.CD006103.pub7

  2. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  3. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Version of Record online : 20 NOV 2013, DOI: 10.1111/adb.12108

  4. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12588

  5. Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1439–1448, Dr Hélène M. Faessel, Dr Megan A. Gibbs, Dr David J. Clark, Mr Kevin Rohrbacher, Dr Marilyn Stolar and Dr Aaron H. Burstein

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006292624

  6. You have free access to this content
    AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1834–1845, Andrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, Daniela Mercatelli, Jennifer Schoch, Michelle Gorman, Alejandra Ramirez, Roberto Ciccocioppo, Taline V Khroyan, Dennis Yasuda, Nurulain T Zaveri, Conrado Pascual, Xinmin (Simon) Xie and Lawrence Toll

    Version of Record online : 23 JAN 2015, DOI: 10.1111/bph.13034

  7. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Version of Record online : 25 JUN 2014, DOI: 10.1111/bph.12690

  8. Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In VitroIn Vivo Study

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 567–576, B Feng, RS Obach, AH Burstein, DJ Clark, SM de Morais and HM Faessel

    Version of Record online : 31 OCT 2007, DOI: 10.1038/sj.clpt.6100405

  9. Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 991–998, Dr Hélène M. Faessel, Dr Bill J. Smith, Dr Megan A. Gibbs, Dr Jason S. Gobey, Dr David J. Clark and Dr Aaron H. Burstein

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006290669

  10. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 9, September 2014, Pages: 1554–1563, Shadi Nahvi, Yuming Ning, Kate S. Segal, Kimber P. Richter and Julia H. Arnsten

    Version of Record online : 27 JUN 2014, DOI: 10.1111/add.12631

  11. Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 607–614, SL McColl, AH Burstein, KR Reeves, CB Billing Jr, M Stolar and EM Sellers

    Version of Record online : 20 FEB 2008, DOI: 10.1038/sj.clpt.6100510

  12. Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings

    Alcoholism: Clinical and Experimental Research

    Volume 40, Issue 7, July 2016, Pages: 1567–1576, Terril L. Verplaetse, Brian P. Pittman, Julia M. Shi, Jeanette M. Tetrault, Sabrina Coppola and Sherry A. McKee

    Version of Record online : 1 JUN 2016, DOI: 10.1111/acer.13110

  13. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1086–1092, Mira Harrison-Woolrych, Helen Paterson and Ming Tan

    Version of Record online : 8 AUG 2013, DOI: 10.1002/pds.3489

  14. You have free access to this content
    Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells

    Journal of Neurochemistry

    Volume 140, Issue 1, January 2017, Pages: 37–52, Arik J. Hone, J. Michael McIntosh, Lola Rueda-Ruzafa, Juan Passas, Cristina de Castro-Guerín, Jesús Blázquez, Carmen González-Enguita and Almudena Albillos

    Version of Record online : 9 DEC 2016, DOI: 10.1111/jnc.13883

  15. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities

    Journal of Evaluation in Clinical Practice

    Volume 17, Issue 2, April 2011, Pages: 288–297, Evelina A. Zimovetz, Koo Wilson, Miny Samuel and Stephen M. Beard

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1365-2753.2010.01439.x

  16. Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1421–1429, Dr Aaron H. Burstein, Dr David J. Clark, Ms Melissa O'Gorman, Dr Susan A. Willavize, Mr Timothy G. Brayman, Mr G. Scott Grover, Mr Robert L. Walsky, Dr R. Scott Obach and Dr Hélène M. Faessel

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307574

  17. Clinical experience of varenicline for smoking cessation

    The Clinical Respiratory Journal

    Volume 4, Issue 4, October 2010, Pages: 215–221, Jae Woo Jung, Eun Ju Jeon, Jae Gyu Kim, Suh-Yoon Yang, Jae Chol Choi, Jong Wook Shin, In Won Park, Byoung Whui Choi, Don-Kyu Kim and Jae Yeol Kim

    Version of Record online : 9 DEC 2009, DOI: 10.1111/j.1752-699X.2009.00178.x

  18. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

    Addiction

    Volume 108, Issue 8, August 2013, Pages: 1497–1502, Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis and Robert West

    Version of Record online : 13 MAY 2013, DOI: 10.1111/add.12219

  19. Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 492–501, Dr Qinying Zhao, Dr Elias Schwam, Dr Terence Fullerton, Ms Melissa O'Gorman and Dr Aaron H. Burstein

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010370461

  20. Prescribing of smoking cessation medication in England since the introduction of varenicline

    Addiction

    Volume 106, Issue 7, July 2011, Pages: 1319–1324, Tessa E. Langley, Yue Huang, Ann McNeill, Tim Coleman, Lisa Szatkowski and Sarah Lewis

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1360-0443.2011.03426.x